You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 8, August 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Bullous Diseases
 •Pemphigus
 •Alert me on articles by topic

The Pathophysiological Significance of Nondesmoglein Targets of Pemphigus Autoimmunity

Development of Antibodies Against Keratinocyte Cholinergic Receptors in Patients With Pemphigus Vulgaris and Pemphigus Foliaceus

Vu Thuong Nguyen; Tou X. Lee, MS; Assane Ndoye, MD; Leonard D. Shultz, PhD; Mark R. Pittelkow, MD; Mark V. Dahl, MD; Peter J. Lynch, MD; Sergei A. Grando, MD, PhD, DSc

Arch Dermatol. 1998;134:971-980.

Objectives  To determine whether nondesmoglein (non-Dsg) autoantibodies are pathogenic and whether they recognize keratinocyte cholinergic receptors that control cell adhesion because antikeratinocyte autoimmunity in patients with pemphigus vulgaris is not limited to the development of autoantibodies to Dsg.

Design  To determine whether non-Dsg autoantibodies are pathogenic, we sought to induce pemphigus in genetically engineered neonatal mice lacking Dsg 3 using pemphigus vulgaris IgGs that did not cross-react with Dsg 1. To determine whether pemphigus autoimmunity involves keratinocyte cholinergic receptors, the latter were separated from cell membranes of human keratinocytes, tagged with the covalent label [3H]propylbenzilylcholine mustard, and used as an antigen in a radioimmunoprecipitation assay of 34 pemphigus vulgaris and 6 pemphigus foliaceus serum samples.

Setting  The dermatologic clinics of the University of Minnesota, Minneapolis; the Mayo Clinic, Rochester, Minn; and the University of California–Davis Medical Center, Sacramento.

Patients  Serum samples were collected from 34 patients with pemphigus vulgaris and 6 patients with pemphigus foliaceus (aged 31-89 years) and from 7 age-similar patients of both sexes with nonpemphigus blistering or the following immune-mediated conditions: pemphigoid gestationis, bullous drug eruption, lupus erythematosus, erythema nodosum, urticaria, acute contact dermatitis, and skin ulcers.

Main Outcome Measures  Clinical, laboratory, and histopathologic findings.

Results  Extensive skin blistering accompanied by the Nikolsky sign and suprabasilar acantholysis was induced in the Dsg3null mice that received pemphigus, but not normal human IgGs. In the radioimmunoprecipitation assays for reactivity with cholinergic receptors, the mean radioactivity precipitated by pemphigus serum samples significantly exceeded both normal- and disease-control levels (P=.001-.02). The mean individual levels of radioactivity precipitated by 34 pemphigus vulgaris and pemphigus foliaceus serum samples (85%) exceeded control values by a mean of approximately 2.6 times.

Conclusions  Autoantibodies to keratinocyte cell-surface molecules other than Dsg 1 and Dsg 3 can induce clinical features of pemphigus vulgaris. Patients with pemphigus vulgaris and those with pemphigus foliaceus develop IgG antibodies that precipitate radiolabeled cholinergic receptors. Because these receptors control keratinocyte adhesion and motility, their inactivation by autoantibodies may elicit intracellular signals that cause disassembly of desmosomes, leading to acantholysis and blistering.


From the Department of Dermatology, University of California–Davis Medical Center, Sacramento (Mr Nguyen and Drs Ndoye, Lynch, and Grando); the Department of Dermatology, University of Minnesota, Minneapolis (Mr Lee and Dr Dahl); The Jackson Laboratory, Bar Harbor, Me (Dr Shultz); and the Department of Dermatology, Mayo Clinic, Rochester, Minn (Dr Pittelkow).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome
Stanley and Amagai
NEJM 2006;355:1800-1810.
FULL TEXT  

Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.
Roosterman et al.
Physiol. Rev. 2006;86:1309-1379.
ABSTRACT | FULL TEXT  

Successful Treatment of Recalcitrant Pemphigus Vulgaris and Pemphigus Vegetans With Etanercept and Carbon Dioxide Laser
Lin et al.
Arch Dermatol 2005;141:680-682.
FULL TEXT  

Pemphigus Vulgaris Acantholysis Ameliorated by Cholinergic Agonists
Nguyen et al.
Arch Dermatol 2004;140:327-334.
ABSTRACT | FULL TEXT  

Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes
Nguyen et al.
J. Biol. Chem. 2004;279:2135-2146.
ABSTRACT | FULL TEXT  

Induction of Pemphigus Phenotype by a Mouse Monoclonal Antibody Against the Amino-Terminal Adhesive Interface of Desmoglein 3
Tsunoda et al.
J. Immunol. 2003;170:2170-2178.
ABSTRACT | FULL TEXT  

Classification, Clinical Manifestations, and Immunopathological Mechanisms of the Epithelial Variant of Paraneoplastic Autoimmune Multiorgan Syndrome: A Reappraisal of Paraneoplastic Pemphigus
Nguyen et al.
Arch Dermatol 2001;137:193-206.
ABSTRACT | FULL TEXT  

Programmed cell death of keratinocytes culminates in apoptotic secretion of a humectant upon secretagogue action of acetylcholine
Nguyen et al.
J. Cell Sci. 2001;114:1189-1204.
ABSTRACT  

Novel Human {alpha}9 Acetylcholine Receptor Regulating Keratinocyte Adhesion is Targeted by Pemphigus Vulgaris Autoimmunity
Nguyen et al.
Am. J. Pathol. 2000;157:1377-1391.
ABSTRACT | FULL TEXT  

Nicotine and Pemphigus
Grando and Dahl
Arch Dermatol 2000;136:1269-1269.
FULL TEXT  

Pemphigus Vulgaris Antibody Identifies Pemphaxin. A NOVEL KERATINOCYTE ANNEXIN-LIKE MOLECULE BINDING ACETYLCHOLINE
Nguyen et al.
J. Biol. Chem. 2000;275:29466-29476.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.